Investment Analysis News 8 October 2025

CIFR Stock Skyrockets 320% After Google-Backed AI Mining Deal – Bubble or Boom?

Company Background & Business Model Cipher Mining is a pure-play Bitcoin miner that specializes in large-scale, energy-efficient data-center mining ts2.tech. It locates facilities “behind the meter” at low-cost renewable power sites in West Texas ts2.tech. Its flagship “Black Pearl” complex

9 October 2025

Turn Therapeutics (TTRX) Skyrockets After Nasdaq Debut – Biotech Breakthrough or Hype?

Company Profile – Background & Leadership Turn Therapeutics, Inc. is a Westlake Village, CA-based biotech company founded in 2015 renaissancecapital.com. The company (formerly named Global Health Solutions, Inc.) officially rebranded to Turn Therapeutics in Sept 2025 ahead of its Nasdaq listing stockanalysis.com. Turn’s

9 October 2025

Biotech · Healthcare Innovation · Investment Analysis · IPO · NASDAQ:TTRX · Stock Market

Intellia Therapeutics Stock Soars on Gene-Editing Breakthrough – Analysts Eye 70–100% Upside

Intellia Background and Pipeline Intellia was an early pioneer of in-vivo CRISPR therapy. Based in Cambridge, MA, it was among the first to administer CRISPR-Cas9 therapies directly into patients ts2.tech. In 2021 Intellia reported the first clinical proof that in-body

9 October 2025

Biotechnology · Gene Editing · Investment Analysis · NASDAQ:NTLA · Pharma News · Stock Market

PepsiCo (PEP) Stock: Q3 Earnings Surprise, “Ozempic Effect” Fears & Activist Investor Shake-Up – What’s Next?

Key Data & Metrics (as of October 9, 2025) Metric Value Stock Price (Oct 8, 2025) $138.84 (close) marketbeat.comDown ~6% in past month; ~–6% YTD finviz.com indexbox.io 52-Week Range Low $127.60 – High $177.48 markets.businessinsider.com Market Capitalization ~$193 Billion markets.businessinsider.com

9 October 2025

Corporate News · Earnings Reports · Financial Trends · Investment Analysis · NYSE:PEP · Stock Market

Tilray’s 300% Rally and Surprise Profit: Is the Cannabis Comeback Real?

Tilray’s Strong Quarter Signals a Turnaround Tilray Brands kicked off its fiscal 2026 with better-than-expected results, signaling that aggressive cost-cutting and diversification efforts are bearing fruit. The company’s Q1 FY2026 revenue hit $209.5 million, a 5% increase over last year’s

9 October 2025

Cannabis Industry · Company Earnings · Investment Analysis · Market Trends · NASDAQ:TLRY · Stock Market

Tempus AI (TEM) Stock Skyrockets on AI Healthcare Breakthroughs – Inside the Price Surge, Latest News & 2025 Outlook

Stock Price Surge: From IPO to Record Highs Tempus AI’s stock has been on a remarkable tear since its mid-2024 IPO. The Chicago-based healthtech firm – founded in 2015 by Eric Lefkofsky (of Groupon fame) – went public in June

9 October 2025

2025 Forecast · AI Healthcare · Investment Analysis · Stock Market News · Technology Trends

UiPath’s Automation Stock Soars on AI Buzz – Latest PATH Analysis & Outlook

Stock Performance: Hitting New Highs on AI Momentum UiPath’s stock has been on a tear in early October 2025, propelled by excitement around artificial intelligence. On October 8, PATH jumped 5.13% to close at $15.58 – its highest closing price since

9 October 2025

AI Trends · Automation · Investment Analysis · NYSE:PATH · Stock Market · Technology News

CrowdStrike Stock Skyrockets Amid Cybersecurity Boom – Is the Rally Justified? (2025 Update)

Sources: Official company reports and press releases; Yahoo Finance and Zacks Investment Research; Reuters and CNBC interviews; TS2 Tech stock analysis and cybersecurity news ts2.tech nasdaq.com markets.financialcontent.com marketbeat.com ts2.tech siliconangle.com ts2.tech. These provide the latest financial data, expert commentary, and industry context

8 October 2025

Cybersecurity · Financial News · Investment Analysis · NASDAQ:CRWD · Stock Market · Technology Trends

CRISPR Therapeutics Stock Update (Oct 8 2025): Why Gene‑Editing Bulls See Big Upside

Stock Price, Volume and Sentiment According to AAII, CRSP’s share price on 8 Oct 2025 closed at $77.727, up 10.06 % from the previous close. The stock traded between $70.77 and $78.38 that day and has risen ~20 % during October. Over the prior

8 October 2025

Biotechnology · Gene Editing · Investment Analysis · Market Trends · NASDAQ:CRSP · Stocks

Intellia Therapeutics (NTLA) Soars on CRISPR Breakthroughs – Latest Updates & Stock Outlook

Intellia at a Glance: CRISPR Trailblazer in 2025 Intellia Therapeutics, Inc. (NASDAQ: NTLA) is a clinical-stage biotechnology company at the forefront of CRISPRgene editing medicines. Headquartered in Cambridge, MA, Intellia was one of the first companies to harness CRISPR-Cas9 technology to

8 October 2025

Biotechnology · Gene Editing · Investment Analysis · NASDAQ:NTLA · Pharmaceutical News · Stock Market

Cisco’s $2B AI Windfall: New Tech, Stock Surge & What’s Next for CSCO

Cisco’s Business Model & Market Position Cisco Systems is best known as the world’s largest vendor of networking hardware and software, powering much of the internet’s infrastructure. The company’s business model centers on selling network equipment (like routers, switches, and wireless access points),

8 October 2025

Artificial Intelligence · Cisco Updates · Investment Analysis · NASDAQ:CSCO · Stock Market · Technology News

Quantum Gold Rush: Inside D-Wave (QBTS) Stock’s 2600% Surge – Hype or Game-Changer?

Above sources in brackets. The surge in D-Wave Quantum’s stock price has captivated markets, but is it a quantum leap forward for investors or a bubble waiting to burst? The in-depth report below examines what’s driving the rally, the company’s

8 October 2025

Financial News · Investment Analysis · NASDAQ:QBTS · Quantum Computing · Stock Market · Technology Trends

Investment Analysis News 8 October 2025 - 9 October 2025